{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T20:03:29Z","timestamp":1792267409779,"version":"4.4.0"},"reference-count":262,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,10,1]]},"DOI":"10.1210\/er.2018-00097","type":"journal-article","created":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T14:09:40Z","timestamp":1528898980000},"page":"519-548","source":"Crossref","is-referenced-by-count":241,"title":["Glucocorticoids and Bone: Consequences of Endogenous and Exogenous Excess and Replacement Therapy"],"prefix":"10.1210","volume":"39","author":[{"given":"Rowan S","family":"Hardy","sequence":"first","affiliation":[{"name":"University of Birmingham, Birmingham, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Bone Research Program, ANZAC Research Institute, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus J","family":"Seibel","sequence":"additional","affiliation":[{"name":"Bone Research Program, ANZAC Research Institute, Sydney, New South Wales, Australia"},{"name":"Department of Endocrinology and Metabolism, Concord Repatriation General Hospital, Sydney, New South Wales, Australia"},{"name":"Concord Clinical School, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Concord Repatriation General Hospital, Sydney, New South Wales, Australia"},{"name":"Concord Clinical School, University of Sydney, Sydney, New South Wales, Australia"},{"name":"Adrenal Steroid Laboratory, ANZAC Research Institute, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,6,13]]},"reference":[{"key":"key\n\t\t\t\t20181005135519424_B1","first-page":"137","article-title":"The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism)","volume":"50","author":"Cushing","year":"1932","journal-title":"Bull Johns Hopkins Hosp"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B2","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/annrheumdis-2015-208916","article-title":"Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force","volume":"75","author":"Strehl","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B3","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"Van Staa","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"5","key":"key\n\t\t\t\t20181005135519424_B4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1164\/rccm.2110047","article-title":"The impact of oral corticosteroid use on bone mineral density and vertebral fracture","volume":"166","author":"Walsh","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1677\/JOE-08-0568","article-title":"Bone loss in inflammatory disorders","volume":"201","author":"Hardy","year":"2009","journal-title":"J Endocrinol"},{"issue":"12","key":"key\n\t\t\t\t20181005135519424_B6","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1007\/s00198-017-4189-7","article-title":"Inflammatory diseases and bone fragility","volume":"28","author":"Briot","year":"2017","journal-title":"Osteoporos Int."},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B7","doi-asserted-by":"crossref","first-page":"R265","DOI":"10.1530\/EJE-16-0289","article-title":"Mechanisms in endocrinology: endogenous subclinical hypercortisolism and bone: a clinical review","volume":"175","author":"Chiodini","year":"2016","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1749-6632.2009.05013.x","article-title":"Clinical features associated with glucocorticoid receptor polymorphisms. An overview","volume":"1179","author":"Manenschijn","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"352","key":"key\n\t\t\t\t20181005135519424_B9","doi-asserted-by":"crossref","first-page":"352ra109","DOI":"10.1126\/scitranslmed.aaf9074","article-title":"ABCC1 confers tissue-specific sensitivity to cortisol versus corticosterone: a rationale for safer glucocorticoid replacement therapy","volume":"8","author":"Nixon","year":"2016","journal-title":"Sci Transl Med"},{"issue":"4","key":"key\n\t\t\t\t20181005135519424_B10","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/er.2012-1050","article-title":"11\u03b2-Hydroxysteroid dehydrogenase 1: translational and therapeutic aspects","volume":"34","author":"Gathercole","year":"2013","journal-title":"Endocr Rev"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1530\/EJE-17-0067","article-title":"Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study","volume":"176","author":"Nilsson","year":"2017","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2265.2006.02540.x","article-title":"The role of corticosterone in human hypothalamic\u2013pituitary\u2013adrenal axis feedback","volume":"65","author":"Raubenheimer","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"11","key":"key\n\t\t\t\t20181005135519424_B13","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1210\/endo.136.11.7588219","article-title":"Developmentally regulated expression of adrenal 17\u03b1-hydroxylase cytochrome P450 in the mouse embryo","volume":"136","author":"Keeney","year":"1995","journal-title":"Endocrinology"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B14","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/cphy.c130044","article-title":"The multifaceted mineralocorticoid receptor","volume":"4","author":"Gomez-Sanchez","year":"2014","journal-title":"Compr Physiol"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tem.2017.10.010","article-title":"Therapeutic mechanisms of glucocorticoids","volume":"29","author":"Vandewalle","year":"2018","journal-title":"Trends Endocrinol Metab"},{"issue":"7","key":"key\n\t\t\t\t20181005135519424_B16","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.tem.2017.04.001","article-title":"Nuclear receptor function through genomics: lessons from the glucocorticoid receptor","volume":"28","author":"Cohen","year":"2017","journal-title":"Trends Endocrinol Metab"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B17","doi-asserted-by":"crossref","first-page":"R69","DOI":"10.1530\/JOE-17-0361","article-title":"Animal models to explore the effects of glucocorticoids on skeletal growth and structure","volume":"236","author":"Wood","year":"2018","journal-title":"J Endocrinol"},{"key":"key\n\t\t\t\t20181005135519424_B18","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.steroids.2016.10.008","article-title":"Continuous corticosterone delivery via the drinking water or pellet implantation: a comparative study in mice","volume":"116","author":"Gasparini","year":"2016","journal-title":"Steroids"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1530\/JOE-14-0508","article-title":"Possible role of lymphocytes in glucocorticoid-induced increase in trabecular bone mineral density","volume":"224","author":"Grahnemo","year":"2015","journal-title":"J Endocrinol"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I","article-title":"Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro","volume":"64","author":"Jaiswal","year":"1997","journal-title":"J Cell Biochem"},{"issue":"5411","key":"key\n\t\t\t\t20181005135519424_B21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B22","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1210\/endo-121-6-1985","article-title":"Physiological concentrations of glucocorticoids stimulate formation of bone nodules from isolated rat calvaria cells in vitro","volume":"121","author":"Bellows","year":"1987","journal-title":"Endocrinology"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1210\/endo.134.1.8275945","article-title":"Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone","volume":"134","author":"Cheng","year":"1994","journal-title":"Endocrinology"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B24","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/jcp.1041460306","article-title":"Dexamethasone induction of osteoblast mRNAs in rat marrow stromal cell cultures","volume":"146","author":"Leboy","year":"1991","journal-title":"J Cell Physiol"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/107632700300003323","article-title":"Differentiation of osteoblasts and in vitro bone formation from murine embryonic stem cells","volume":"7","author":"Buttery","year":"2001","journal-title":"Tissue Eng"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/JME-14-0314","article-title":"Glucocorticoid inhibits cell proliferation in differentiating osteoblasts by microRNA-199a targeting of WNT signaling","volume":"54","author":"Shi","year":"2015","journal-title":"J Mol Endocrinol"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B27","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00223-009-9303-1","article-title":"Biphasic glucocorticoid-dependent regulation of Wnt expression and its inhibitors in mature osteoblastic cells","volume":"85","author":"Mak","year":"2009","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"key\n\t\t\t\t20181005135519424_B28","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1074\/jbc.M702687200","article-title":"Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling","volume":"283","author":"Zhou","year":"2008","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20181005135519424_B29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fendo.2011.00024","article-title":"Glucocorticoid-induced osteoporosis\u2014a disorder of mesenchymal stromal cells","volume":"2","author":"Hardy","year":"2011","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B30","doi-asserted-by":"crossref","first-page":"30186","DOI":"10.1038\/srep30186","article-title":"Mesenchymal progenitors in osteopenias of diverse pathologies: differential characteristics in the common shift from osteoblastogenesis to adipogenesis","volume":"6","author":"Sui","year":"2016","journal-title":"Sci Rep"},{"issue":"7","key":"key\n\t\t\t\t20181005135519424_B31","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/1529-0131(199907)42:7<1405::AID-ANR14>3.0.CO;2-W","article-title":"Fat conversion of femoral marrow in glucocorticoid-treated patients: a cross-sectional and longitudinal study with magnetic resonance imaging","volume":"42","author":"Vande Berg","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B32","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1210\/en.2015-1477","article-title":"Expansion of bone marrow adipose tissue during caloric restriction is associated with increased circulating glucocorticoids and not with yypoleptinemia","volume":"157","author":"Cawthorn","year":"2016","journal-title":"Endocrinology"},{"issue":"4","key":"key\n\t\t\t\t20181005135519424_B33","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1210\/en.2003-1427","article-title":"Mice deficient in 11\u03b2-hydroxysteroid dehydrogenase type 1 lack bone marrow adipocytes but maintain normal bone formation","volume":"145","author":"Justesen","year":"2004","journal-title":"Endocrinology."},{"key":"key\n\t\t\t\t20181005135519424_B34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-1-4939-2895-8_8","article-title":"Glucocorticoid-induced osteoporosis","volume":"872","author":"Frenkel","year":"2015","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B35","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1006\/bbrc.2000.4223","article-title":"Regulation of osteoprotegerin secretion from primary cultures of human bone marrow stromal cells","volume":"280","author":"Br\u00e4ndstr\u00f6m","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"key\n\t\t\t\t20181005135519424_B36","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1677\/joe.0.1590191","article-title":"Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: down-regulation by glucocorticoids","volume":"159","author":"Vidal","year":"1998","journal-title":"J Endocrinol"},{"issue":"10","key":"key\n\t\t\t\t20181005135519424_B38","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1038\/nm.2452","article-title":"Evidence for osteocyte regulation of bone homeostasis through RANKL expression","volume":"17","author":"Nakashima","year":"2011","journal-title":"Nat Med"},{"issue":"9","key":"key\n\t\t\t\t20181005135519424_B39","doi-asserted-by":"crossref","first-page":"e0138189","DOI":"10.1371\/journal.pone.0138189","article-title":"Osteocytes, not osteoblasts or lining cells, are the main source of the RANKL required for osteoclast formation in remodeling bone","volume":"10","author":"Xiong","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.3074","article-title":"WNT signaling in bone homeostasis and disease: from human mutations to treatments","volume":"19","author":"Baron","year":"2013","journal-title":"Nat Med"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B41","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbrc.2005.01.117","article-title":"Glucocorticoid suppresses the canonical Wnt signal in cultured human osteoblasts","volume":"329","author":"Ohnaka","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/jcp.25399","article-title":"Glucocorticoids hijack Runx2 to stimulate Wif1 for suppression of osteoblast growth and differentiation","volume":"232","author":"Morimoto","year":"2017","journal-title":"J Cell Physiol"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bbrc.2004.04.025","article-title":"Glucocorticoid enhances the expression of dickkopf-1 in human osteoblasts: novel mechanism of glucocorticoid-induced osteoporosis","volume":"318","author":"Ohnaka","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B44","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"Diarra","year":"2007","journal-title":"Nat Med."},{"issue":"9","key":"key\n\t\t\t\t20181005135519424_B45","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1128\/MCB.11.9.4490","article-title":"Glucocorticoid regulation of transforming growth factor beta 1 activity and binding in osteoblast-enriched cultures from fetal rat bone","volume":"11","author":"Centrella","year":"1991","journal-title":"Mol Cell Biol"},{"issue":"4","key":"key\n\t\t\t\t20181005135519424_B46","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1210\/endo-115-4-1577","article-title":"Characterization of insulin-like growth factor I receptors on cultured rat bone cells: regulation of receptor concentration by glucocorticoids","volume":"115","author":"Bennett","year":"1984","journal-title":"Endocrinology"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B47","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1210\/endo-126-3-1569","article-title":"Cortisol inhibits the synthesis of insulin-like growth factor-I in skeletal cells","volume":"126","author":"McCarthy","year":"1990","journal-title":"Endocrinology"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B48","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2010.05.005","article-title":"Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor","volume":"11","author":"Rauch","year":"2010","journal-title":"Cell Metab"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B49","first-page":"664","article-title":"Glucocorticoids Induce bone and muscle atrophy by tissue-specific mechanisms upstream of E3 ubiquitin ligases","volume":"158","author":"Sato","year":"2017","journal-title":"Endocrinology"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B50","first-page":"115","article-title":"Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocr Rev"},{"issue":"33","key":"key\n\t\t\t\t20181005135519424_B51","doi-asserted-by":"crossref","first-page":"24120","DOI":"10.1074\/jbc.M611435200","article-title":"Glucocorticoids induce osteocyte apoptosis by blocking focal adhesion kinase-mediated survival. Evidence for inside-out signaling leading to anoikis","volume":"282","author":"Plotkin","year":"2007","journal-title":"J Biol Chem"},{"issue":"10","key":"key\n\t\t\t\t20181005135519424_B52","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI6800","article-title":"Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin","volume":"104","author":"Plotkin","year":"1999","journal-title":"J Clin Invest"},{"issue":"52","key":"key\n\t\t\t\t20181005135519424_B53","doi-asserted-by":"crossref","first-page":"44326","DOI":"10.1074\/jbc.M111.283481","article-title":"Glucocorticoids and tumor necrosis factor \u03b1 increase oxidative stress and suppress Wnt protein signaling in osteoblasts","volume":"286","author":"Almeida","year":"2011","journal-title":"J Biol Chem"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B54","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/jcp.21335","article-title":"Regulation of bim in glucocorticoid-mediated osteoblast apoptosis","volume":"215","author":"Espina","year":"2008","journal-title":"J Cell Physiol"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B55","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s00223-014-9847-6","article-title":"Glucocorticoid induced osteoblast apoptosis by increasing E4BP4 expression via up-regulation of Bim","volume":"94","author":"Chen","year":"2014","journal-title":"Calcif Tissue Int"},{"issue":"2-3","key":"key\n\t\t\t\t20181005135519424_B56","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.tox.2009.01.016","article-title":"Anti-inflammatory drugs suppress proliferation and induce apoptosis through altering expressions of cell cycle regulators and pro-apoptotic factors in cultured human osteoblasts","volume":"258","author":"Chang","year":"2009","journal-title":"Toxicology"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B57","doi-asserted-by":"crossref","first-page":"e37030","DOI":"10.1371\/journal.pone.0037030","article-title":"Glucocorticoid receptor and sequential P53 activation by dexamethasone mediates apoptosis and cell cycle arrest of osteoblastic MC3T3-E1 cells","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B58","doi-asserted-by":"crossref","first-page":"36513","DOI":"10.1038\/srep36513","article-title":"Strain dependent differences in glucocorticoid-induced bone loss between C57BL\/6J and CD-1 mice","volume":"6","author":"Ersek","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B59","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J Clin Invest"},{"issue":"2\u20134","key":"key\n\t\t\t\t20181005135519424_B60","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000324745","article-title":"Ectopic expression of Col2.3 and Col3.6 promoters in the brain and association with leptin signaling","volume":"194","author":"Scheller","year":"2011","journal-title":"Cells Tissues Organs"},{"issue":"5","key":"key\n\t\t\t\t20181005135519424_B61","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00774-004-0504-4","article-title":"Expression of dentin matrix protein 1 (DMP1) in nonmineralized tissues","volume":"22","author":"Terasawa","year":"2004","journal-title":"J Bone Miner Metab"},{"key":"key\n\t\t\t\t20181005135519424_B62","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3389\/fphys.2016.00456","article-title":"Nerve growth factor, brain-derived neurotrophic factor and osteocalcin gene relationship in energy regulation, bone homeostasis and reproductive organs analyzed by mRNA quantitative evaluation and linear correlation analysis","volume":"7","author":"Camerino","year":"2016","journal-title":"Front Physiol"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B63","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.yfrne.2010.12.001","article-title":"11\u03b2-Hydroxysteroid dehydrogenases and the brain: from zero to hero, a decade of progress","volume":"32","author":"Wyrwoll","year":"2011","journal-title":"Front Neuroendocrinol"},{"issue":"12","key":"key\n\t\t\t\t20181005135519424_B64","first-page":"4490","article-title":"Expression of type 2 11\u03b2-hydroxysteroid dehydrogenase and corticosteroid hormone receptors in early human fetal life","volume":"83","author":"Condon","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B65","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1210\/endo.142.3.8044","article-title":"Cloning and in vitro characterization of \u03b1 1(I)-collagen 11\u03b2-hydroxysteroid dehydrogenase type 2 transgenes as models for osteoblast-selective inactivation of natural glucocorticoids","volume":"142","author":"Woitge","year":"2001","journal-title":"Endocrinology"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B66","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1096\/fj.01-0582com","article-title":"Prereceptor regulation of glucocorticoid action by 11\u03b2-hydroxysteroid dehydrogenase: a novel determinant of cell proliferation","volume":"16","author":"Rabbitt","year":"2002","journal-title":"FASEB J"},{"issue":"4","key":"key\n\t\t\t\t20181005135519424_B67","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/en.2003-0990","article-title":"Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength","volume":"145","author":"O\u2019Brien","year":"2004","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20181005135519424_B68","author":"Dunstan"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B69","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1210\/en.2003-0655","article-title":"Transgenic expression of 11\u03b2-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone","volume":"145","author":"Sher","year":"2004","journal-title":"Endocrinology"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1359\/jbmr.2002.17.1.15","article-title":"Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage","volume":"17","author":"Kalajzic","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B71","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1242\/dev.027706","article-title":"Glucocorticoid-dependent Wnt signaling by mature osteoblasts is a key regulator of cranial skeletal development in mice","volume":"136","author":"Zhou","year":"2009","journal-title":"Development"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B72","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bone.2009.03.673","article-title":"Endogenous glucocorticoid signalling in osteoblasts is necessary to maintain normal bone structure in mice","volume":"45","author":"Kalak","year":"2009","journal-title":"Bone"},{"issue":"4","key":"key\n\t\t\t\t20181005135519424_B73","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.bone.2011.06.013","article-title":"Corticosterone selectively targets endo-cortical surfaces by an osteoblast-dependent mechanism","volume":"49","author":"Henneicke","year":"2011","journal-title":"Bone"},{"issue":"8","key":"key\n\t\t\t\t20181005135519424_B74","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1359\/jbmr.2001.16.8.1496","article-title":"Colocalization of glucocorticoid and mineralocorticoid receptors in human bone","volume":"16","author":"Beavan","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B75","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.bbrc.2014.03.149","article-title":"Mineralocorticoid receptor function in bone metabolism and its role in glucocorticoid-induced osteopenia","volume":"447","author":"Fumoto","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B76","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1210\/endo.142.3.8048","article-title":"Regional trabecular bone matrix degeneration and osteocyte death in femora of glucocorticoid- treated rabbits","volume":"142","author":"Eberhardt","year":"2001","journal-title":"Endocrinology"},{"issue":"8","key":"key\n\t\t\t\t20181005135519424_B77","first-page":"2907","article-title":"Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip","volume":"85","author":"Weinstein","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"key\n\t\t\t\t20181005135519424_B78","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1096\/fj.11-182519","article-title":"Glucocorticoid dose determines osteocyte cell fate","volume":"25","author":"Jia","year":"2011","journal-title":"FASEB J"},{"issue":"4","key":"key\n\t\t\t\t20181005135519424_B79","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI6610","article-title":"Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone","volume":"104","author":"Jilka","year":"1999","journal-title":"J Clin Invest"},{"issue":"9","key":"key\n\t\t\t\t20181005135519424_B80","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1210\/en.2011-0170","article-title":"Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice","volume":"152","author":"Weinstein","year":"2011","journal-title":"Endocrinology"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B81","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1210\/en.2009-1488","article-title":"Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice","volume":"151","author":"Weinstein","year":"2010","journal-title":"Endocrinology"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B82","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1474-9726.2009.00545.x","article-title":"Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice","volume":"9","author":"Weinstein","year":"2010","journal-title":"Aging Cell"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B83","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1359\/JBMR.051103","article-title":"Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice","volume":"21","author":"Lane","year":"2006","journal-title":"J Bone Miner Res"},{"issue":"11","key":"key\n\t\t\t\t20181005135519424_B84","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1002\/jbmr.160","article-title":"Glucocorticoid-induced autophagy in osteocytes","volume":"25","author":"Xia","year":"2010","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t20181005135519424_B85","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bone.2015.02.005","article-title":"Suppression of autophagy in osteocytes does not modify the adverse effects of glucocorticoids on cortical bone","volume":"75","author":"Piemontese","year":"2015","journal-title":"Bone"},{"key":"key\n\t\t\t\t20181005135519424_B86","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bone.2015.01.001","article-title":"Prevention of glucocorticoid induced bone changes with beta-ecdysone","volume":"74","author":"Dai","year":"2015","journal-title":"Bone"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B87","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1136\/annrheumdis-2015-207240","article-title":"Inactivation of autophagy ameliorates glucocorticoid-induced and ovariectomy-induced bone loss","volume":"75","author":"Lin","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20181005135519424_B88","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2015.06.014","article-title":"Glucocorticoids: Dose-related effects on osteoclast formation and function via reactive oxygen species and autophagy","volume":"79","author":"Shi","year":"2015","journal-title":"Bone"},{"issue":"5","key":"key\n\t\t\t\t20181005135519424_B89","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/er.2012-1026","article-title":"The osteocyte: an endocrine cell ... and more","volume":"34","author":"Dallas","year":"2013","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t20181005135519424_B90","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/jbmr.2869","article-title":"Protection from glucocorticoid-induced osteoporosis by anti-catabolic signaling in the absence of Sost\/sclerostin","volume":"31","author":"Sato","year":"2016","journal-title":"J Bone Miner Res"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B91","doi-asserted-by":"crossref","first-page":"E587","DOI":"10.1152\/ajpendo.00219.2016","article-title":"Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice","volume":"311","author":"Piemontese","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B92","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00198-015-3308-6","article-title":"Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength","volume":"27","author":"Yao","year":"2016","journal-title":"Osteoporos Int."},{"key":"key\n\t\t\t\t20181005135519424_B93","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.bone.2015.09.010","article-title":"Sclerostin antibody and interval treadmill training effects in a rodent model of glucocorticoid-induced osteopenia","volume":"81","author":"Achiou","year":"2015","journal-title":"Bone"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B94","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1359\/JBMR.041233","article-title":"Influence of glucocorticoids on human osteoclast generation and activity","volume":"20","author":"Sivagurunathan","year":"2005","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t20181005135519424_B95","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bone.2016.08.024","article-title":"Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity","volume":"93","author":"Conaway","year":"2016","journal-title":"Bone"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B96","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1677\/joe.0.1750155","article-title":"Effect of corticosteroids on human osteoclast formation and activity","volume":"175","author":"Hirayama","year":"2002","journal-title":"J Endocrinol"},{"issue":"8","key":"key\n\t\t\t\t20181005135519424_B97","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1172\/JCI28084","article-title":"Glucocorticoids suppress bone formation via the osteoclast","volume":"116","author":"Kim","year":"2006","journal-title":"J Clin Invest"},{"issue":"12","key":"key\n\t\t\t\t20181005135519424_B98","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/en.2006-0459","article-title":"Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density","volume":"147","author":"Jia","year":"2006","journal-title":"Endocrinology"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B99","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1677\/joe.0.1540397","article-title":"Glucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis","volume":"154","author":"Dempster","year":"1997","journal-title":"J Endocrinol"},{"issue":"7","key":"key\n\t\t\t\t20181005135519424_B100","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1210\/en.2005-0717","article-title":"Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-\u03baB (NF-\u03baB) ligand, osteoprotegerin, and receptor activator of NF-\u03baB in mouse calvarial bones","volume":"147","author":"Swanson","year":"2006","journal-title":"Endocrinology"},{"issue":"8","key":"key\n\t\t\t\t20181005135519424_B101","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1172\/JCI0214538","article-title":"Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids","volume":"109","author":"Weinstein","year":"2002","journal-title":"J Clin Invest"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B102","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/jbmr.2322","article-title":"Anabolic bone formation via a site-specific bone-targeting delivery system by interfering with semaphorin 4D expression","volume":"30","author":"Zhang","year":"2015","journal-title":"J Bone Miner Res."},{"key":"key\n\t\t\t\t20181005135519424_B103","doi-asserted-by":"crossref","first-page":"15831","DOI":"10.1038\/ncomms15831","article-title":"Optogenetic activation of Plexin-B1 reveals contact repulsion between osteoclasts and osteoblasts","volume":"8","author":"Deb Roy","year":"2017","journal-title":"Nat Commun"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B104","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/0003-4819-129-3-199808010-00012","article-title":"Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: clinical implications","volume":"129","author":"Chrousos","year":"1998","journal-title":"Ann Intern Med"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B105","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.semarthrit.2015.04.014","article-title":"Evolutionary medicine and bone loss in chronic inflammatory diseases\u2014a theory of inflammation-related osteopenia","volume":"45","author":"Straub","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"key\n\t\t\t\t20181005135519424_B106","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1359\/jbmr.2000.15.9.1645","article-title":"Corticosteroid osteoporosis: practical implications of recent trials","volume":"15","author":"Sambrook","year":"2000","journal-title":"J Bone Miner Res"},{"issue":"12","key":"key\n\t\t\t\t20181005135519424_B107","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/rheumatology\/38.12.1239","article-title":"Osteopenia in young hypogonadal women with systemic lupus erythematosus receiving chronic steroid therapy: a randomized controlled trial comparing calcitriol and hormonal replacement therapy","volume":"38","author":"Kung","year":"1999","journal-title":"Rheumatology (Oxford)"},{"issue":"10","key":"key\n\t\t\t\t20181005135519424_B108","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/art.1780371014","article-title":"Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids","volume":"37","author":"Hall","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"7","key":"key\n\t\t\t\t20181005135519424_B109","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1210\/jc.2002-021827","article-title":"Randomized placebo-controlled trial of androgen effects on muscle and bone in men requiring long-term systemic glucocorticoid treatment","volume":"88","author":"Crawford","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"key\n\t\t\t\t20181005135519424_B110","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI3914","article-title":"Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial","volume":"102","author":"Lane","year":"1998","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20181005135519424_B111","first-page":"381","article-title":"Effects of glucocorticoids on calcium and phosphate excretion","volume":"171","author":"Ritz","year":"1984","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B112","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/jcem-40-1-152","article-title":"Effect of glucocorticoids on function of the parathyroid glands in man","volume":"40","author":"Fucik","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key\n\t\t\t\t20181005135519424_B113","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1210\/jc.2002-012101","article-title":"Clinical review 151: the role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a re-examination of the evidence","volume":"87","author":"Rubin","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key\n\t\t\t\t20181005135519424_B114","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.2007-0036","article-title":"Growth hormone, insulin-like growth factors, and the skeleton","volume":"29","author":"Giustina","year":"2008","journal-title":"Endocr Rev"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B115","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1053\/meta.2002.28972","article-title":"Growth hormone has anabolic effects in glucocorticosteroid-dependent children with inflammatory bowel disease: a pilot study","volume":"51","author":"Mauras","year":"2002","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t20181005135519424_B116","first-page":"82","article-title":"Treatment of juvenile rheumatoid arthritis with growth hormone","volume":"53","author":"Simon","year":"2000","journal-title":"Horm Res"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B117","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jbmr.5650050608","article-title":"Muscle strength as a predictor of bone mineral density in young women","volume":"5","author":"Snow-Harter","year":"1990","journal-title":"J Bone Miner Res"},{"issue":"5","key":"key\n\t\t\t\t20181005135519424_B118","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1365-2362.2002.00993.x","article-title":"Effects of high doses of glucocorticoids on free amino acids, ribosomes and protein turnover in human muscle","volume":"32","author":"L\u00f6fberg","year":"2002","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"key\n\t\t\t\t20181005135519424_B119","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/en.2004-1594","article-title":"Insulin-like growth factor-I gene transfer by electroporation prevents skeletal muscle atrophy in glucocorticoid-treated rats","volume":"146","author":"Schakman","year":"2005","journal-title":"Endocrinology"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1042\/bj1780139","article-title":"Effect of glucocorticoid administration on the rate of muscle protein breakdown in vivo in rats, as measured by urinary excretion of NT-methylhistidine","volume":"178","author":"Tomas","year":"1979","journal-title":"Biochem J"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B121","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/rheumatology\/keh404","article-title":"Functional outcome and quality of life in adult patients with idiopathic inflammatory myositis","volume":"44","author":"Ponyi","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"key\n\t\t\t\t20181005135519424_B122","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/path.4806","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 within muscle protects against the adverse effects of local inflammation","volume":"240","author":"Hardy","year":"2016","journal-title":"J Pathol"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B123","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1210\/er.2012-1042","article-title":"The impact of diabetes and diabetes medications on bone health","volume":"36","author":"Gilbert","year":"2015","journal-title":"Endocr Rev"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B124","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S2213-8587(15)00283-1","article-title":"Type 2 diabetes and the skeleton: new insights into sweet bones","volume":"4","author":"Shanbhogue","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B125","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1530\/JOE-14-0373","article-title":"Glucocorticoid treatment and endocrine pancreas function: implications for glucose homeostasis, insulin resistance and diabetes","volume":"223","author":"Rafacho","year":"2014","journal-title":"J Endocrinol"},{"issue":"5","key":"key\n\t\t\t\t20181005135519424_B126","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/annrheumdis-2016-209954","article-title":"Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis","volume":"76","author":"Ozen","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"key\n\t\t\t\t20181005135519424_B127","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1172\/JCI63377","article-title":"Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism","volume":"122","author":"Brennan-Speranza","year":"2012","journal-title":"J Clin Invest"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B128","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","article-title":"Endocrine regulation of energy metabolism by the skeleton","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B129","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1210\/jc.2014-3019","article-title":"Higher serum undercarboxylated osteocalcin and other bone turnover markers are associated with reduced diabetes risk and lower estradiol concentrations in older men","volume":"100","author":"Yeap","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key\n\t\t\t\t20181005135519424_B130","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1210\/en.2015-2010","article-title":"Evidence for osteocalcin binding and activation of GPRC6A in \u03b2-cells","volume":"157","author":"Pi","year":"2016","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t20181005135519424_B131","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bone.2014.07.008","article-title":"Outcome of glucose homeostasis in patients with glucocorticoid-induced osteoporosis undergoing treatment with bone active-drugs","volume":"67","author":"Mazziotti","year":"2014","journal-title":"Bone"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B132","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1530\/JOE-17-0147","article-title":"Skeletal energy homeostasis: a paradigm of endocrine discovery","volume":"234","author":"Suchacki","year":"2017","journal-title":"J Endocrinol"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B133","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1172\/JCI97794","article-title":"Vhl deletion in osteoblasts boosts cellular glycolysis and improves global glucose metabolism","volume":"128","author":"Dirckx","year":"2018","journal-title":"J Clin Invest"},{"issue":"24","key":"key\n\t\t\t\t20181005135519424_B134","doi-asserted-by":"crossref","first-page":"E2482","DOI":"10.1073\/pnas.1323681111","article-title":"11\u03b2-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess","volume":"111","author":"Morgan","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B135","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bone.2010.06.002","article-title":"Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation","volume":"47","author":"Yang","year":"2010","journal-title":"Bone"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/cen.12189","article-title":"Glucocorticoid-induced osteoporosis: lessons from Cushing\u2019s syndrome","volume":"79","author":"T\u00f3th","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B137","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/eje.0.1460051","article-title":"Increased risk of osteoporotic fractures in patients with Cushing\u2019s syndrome","volume":"146","author":"Vestergaard","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t20181005135519424_B138","doi-asserted-by":"crossref","unstructured":"Kendler DL , BauerDC, DavisonKS, DianL, HanleyDA, HarrisST, McClungMR, MillerPD, SchousboeJT, YuenCK, LewieckiEM. Vertebral fractures: clinical importance and management. Am J Med. 2016;129(2):221.e1-10.","DOI":"10.1016\/j.amjmed.2015.09.020"},{"issue":"5","key":"key\n\t\t\t\t20181005135519424_B139","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jama.2009.50","article-title":"Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women","volume":"301","author":"Bliuc","year":"2009","journal-title":"JAMA"},{"issue":"9","key":"key\n\t\t\t\t20181005135519424_B140","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique","volume":"8","author":"Genant","year":"1993","journal-title":"J Bone Miner Res."},{"issue":"5","key":"key\n\t\t\t\t20181005135519424_B141","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1210\/jc.2005-0582","article-title":"Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status","volume":"91","author":"Tauchmanov\u00e0","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20181005135519424_B142","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/jbmr.3222","article-title":"Comparative analysis of the radiology of osteoporotic vertebral fractures in women and men: cross-sectional and longitudinal observations from the Canadian Multicentre Osteoporosis Study (CaMos)","volume":"33","author":"Lentle","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B143","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11657-015-0244-1","article-title":"The risk factors for fractures and trabecular bone-score value in patients with endogenous Cushing\u2019s syndrome","volume":"10","author":"Belaya","year":"2015","journal-title":"Arch Osteoporos"},{"issue":"11","key":"key\n\t\t\t\t20181005135519424_B144","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1359\/jbmr.090505","article-title":"Deleterious effects of glucocorticoid replacement on bone in women after long-term remission of Cushing\u2019s syndrome","volume":"24","author":"Barahona","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B145","first-page":"1863","article-title":"Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing\u2019s syndrome","volume":"83","author":"Chiodini","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20181005135519424_B146","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s00198-009-0978-y","article-title":"Bone turnover in patients with endogenous Cushing\u2019s syndrome before and after successful treatment","volume":"21","author":"Szappanos","year":"2010","journal-title":"Osteoporos Int"},{"key":"key\n\t\t\t\t20181005135519424_B147","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/bonekey.2016.42","article-title":"Diagnostic performance of osteocalcin measurements in patients with endogenous Cushing\u2019s syndrome","volume":"5","author":"Belaya","year":"2016","journal-title":"Bonekey Rep"},{"issue":"7","key":"key\n\t\t\t\t20181005135519424_B148","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s00198-007-0514-x","article-title":"Skeletal differences in bone mineral area and content before and after cure of endogenous Cushing\u2019s syndrome","volume":"19","author":"F\u00fct\u0151","year":"2008","journal-title":"Osteoporos Int"},{"issue":"5","key":"key\n\t\t\t\t20181005135519424_B149","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s00268-007-9394-7","article-title":"Bone mineral density before and after surgical cure of Cushing\u2019s syndrome due to adrenocortical adenoma: prospective study","volume":"32","author":"Kawamata","year":"2008","journal-title":"World J Surg"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B150","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2265.1992.tb01437.x","article-title":"Normal bone mineral density following cure of Cushing\u2019s syndrome","volume":"36","author":"Manning","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"key\n\t\t\t\t20181005135519424_B151","first-page":"2859","article-title":"Bone mineral density and bone turnover before and after surgical cure of Cushing\u2019s syndrome","volume":"80","author":"Hermus","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B152","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B153","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.ecl.2015.02.009","article-title":"Adrenal mild hypercortisolism","volume":"44","author":"Goddard","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"9","key":"key\n\t\t\t\t20181005135519424_B154","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1210\/jc.2009-0468","article-title":"Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian multicenter study","volume":"94","author":"Chiodini","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"key\n\t\t\t\t20181005135519424_B155","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/jbmr.1648","article-title":"Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism","volume":"27","author":"Eller-Vainicher","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"11","key":"key\n\t\t\t\t20181005135519424_B156","doi-asserted-by":"crossref","first-page":"5337","DOI":"10.1210\/jcem.86.11.8022","article-title":"Bone loss rate in adrenal incidentalomas: a longitudinal study","volume":"86","author":"Chiodini","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B157","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-2265.2008.03310.x","article-title":"Eugonadal male patients with adrenal incidentalomas and subclinical hypercortisolism have increased rate of vertebral fractures","volume":"70","author":"Chiodini","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"key\n\t\t\t\t20181005135519424_B158","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1210\/jc.2016-1423","article-title":"Prediction of vertebral fractures in patients with monolateral adrenal incidentalomas","volume":"101","author":"Morelli","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"key\n\t\t\t\t20181005135519424_B159","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-147-8-200710160-00006","article-title":"Subclinical hypercortisolism among outpatients referred for osteoporosis","volume":"147","author":"Chiodini","year":"2007","journal-title":"Ann Intern Med"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B160","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/EJE-13-0102","article-title":"Prevalence of subclinical contributors to low bone mineral density and\/or fragility fracture","volume":"169","author":"Eller-Vainicher","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B161","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1530\/EJE-15-0977","article-title":"Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism","volume":"174","author":"Salcuni","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"key\n\t\t\t\t20181005135519424_B162","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/BF03346473","article-title":"Weekly clodronate treatment prevents bone loss and vertebral fractures in women with subclinical Cushing\u2019s syndrome","volume":"32","author":"Tauchmanova","year":"2009","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B163","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00198-010-1524-7","article-title":"Guidance for the adjustment of FRAX according to the dose of glucocorticoids","volume":"22","author":"Kanis","year":"2011","journal-title":"Osteoporos Int"},{"issue":"10","key":"key\n\t\t\t\t20181005135519424_B164","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s00198-008-0588-0","article-title":"Development of prognostic nomograms for individualizing 5-year and 10-year fracture risks","volume":"19","author":"Nguyen","year":"2018","journal-title":"Osteoporos Int"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B165","first-page":"751","article-title":"Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women","volume":"83","author":"Heshmati","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key\n\t\t\t\t20181005135519424_B166","doi-asserted-by":"crossref","first-page":"M479","DOI":"10.1093\/gerona\/54.9.M479","article-title":"Elevated salivary cortisol in the evening in healthy elderly men and women: correlation with bone mineral density","volume":"54","author":"Raff","year":"1999","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"9","key":"key\n\t\t\t\t20181005135519424_B167","first-page":"3058","article-title":"Profiles of endogenous circulating cortisol and bone mineral density in healthy elderly men","volume":"84","author":"Dennison","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B168","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.1365-2265.2007.02978.x","article-title":"Serum fasting cortisol in relation to bone, and the role of genetic variations in the glucocorticoid receptor","volume":"67","author":"van Schoor","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B169","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1365-2265.2005.02281.x","article-title":"Circulating cortisone levels are associated with biochemical markers of bone formation and lumbar spine BMD: the Hertfordshire Cohort Study","volume":"62","author":"Cooper","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B170","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/jbmr.2347","article-title":"Higher glucocorticoid secretion in the physiological range is associated with lower bone strength at the proximal radius in healthy children: importance of protein intake adjustment","volume":"30","author":"Shi","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"7","key":"key\n\t\t\t\t20181005135519424_B171","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1532-5415.1999.tb03835.x","article-title":"The relation between cortisol excretion and fractures in healthy older people: results from the MacArthur studies-Mac","volume":"47","author":"Greendale","year":"1999","journal-title":"J Am Geriatr Soc"},{"issue":"7","key":"key\n\t\t\t\t20181005135519424_B172","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1210\/jc.2016-3804","article-title":"High evening cortisol level is associated with low TBS and increased prevalent vertebral fractures: OsteoLaus Study","volume":"102","author":"Gonzalez Rodriguez","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B173","first-page":"144","article-title":"A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo","volume":"83","author":"Huizenga","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key\n\t\t\t\t20181005135519424_B174","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/j.1365-2265.2009.03528.x","article-title":"BclI polymorphism of the glucocorticoid receptor gene is associated with decreased bone mineral density in patients with endogenous hypercortisolism","volume":"71","author":"Szappanos","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B175","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/cen.12096","article-title":"BclI polymorphism of the glucocorticoid receptor gene is associated with increased bone resorption in patients on glucocorticoid replacement therapy","volume":"78","author":"Koetz","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"key\n\t\t\t\t20181005135519424_B176","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1186\/ar3118","article-title":"Polymorphisms in the glucocorticoid receptor gene that modulate glucocorticoid sensitivity are associated with rheumatoid arthritis","volume":"12","author":"van Oosten","year":"2010","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"key\n\t\t\t\t20181005135519424_B177","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00296-015-3235-z","article-title":"Polymorphisms in the glucocorticoid receptor gene and in the glucocorticoid-induced transcript 1 gene are associated with disease activity and response to glucocorticoid bridging therapy in rheumatoid arthritis","volume":"35","author":"Quax","year":"2015","journal-title":"Rheumatol Int"},{"issue":"4","key":"key\n\t\t\t\t20181005135519424_B178","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/endo.139.4.5917","article-title":"Penetration of dexamethasone into brain glucocorticoid targets is enhanced in mdr1A P-glycoprotein knockout mice","volume":"139","author":"Meijer","year":"1998","journal-title":"Endocrinology"},{"issue":"12","key":"key\n\t\t\t\t20181005135519424_B179","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1210\/jc.2001-011902","article-title":"Human osteoblast-like cells express predominantly steroid 5\u03b1-reductase type 1","volume":"87","author":"Issa","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B180","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1152\/physrev.00020.2012","article-title":"11\u03b2-Hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action","volume":"93","author":"Chapman","year":"2013","journal-title":"Physiol Rev"},{"issue":"10","key":"key\n\t\t\t\t20181005135519424_B181","doi-asserted-by":"crossref","first-page":"6546","DOI":"10.1074\/jbc.M512635200","article-title":"Hexose-6-phosphate dehydrogenase knock-out mice lack 11\u03b2-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation","volume":"281","author":"Lavery","year":"2006","journal-title":"J Biol Chem"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B182","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S8756-3282(98)00084-2","article-title":"Osteoprogenitor cells in cell populations derived from mouse and rat calvaria differ in their response to corticosterone, cortisol, and cortisone","volume":"23","author":"Bellows","year":"1998","journal-title":"Bone"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B183","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1677\/joe.0.1610455","article-title":"Characterization of 11\u03b2-hydroxysteroid dehydrogenase activity and corticosteroid receptor expression in human osteosarcoma cell lines","volume":"161","author":"Bland","year":"1999","journal-title":"J Endocrinol"},{"issue":"4","key":"key\n\t\t\t\t20181005135519424_B184","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1530\/ERC-12-0079","article-title":"Expression of 11\u03b2-hydroxysteroid dehydrogenase enzymes in human osteosarcoma: potential role in pathogenesis and as targets for treatments","volume":"19","author":"Patel","year":"2012","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B185","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S8756-3282(00)00344-6","article-title":"Expression and functional consequences of 11\u03b2-hydroxysteroid dehydrogenase activity in human bone","volume":"27","author":"Cooper","year":"2000","journal-title":"Bone"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B186","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1210\/me.2004-0212","article-title":"11\u03b2-Hydroxysteroid dehydrogenase expression and glucocorticoid synthesis are directed by a molecular switch during osteoblast differentiation","volume":"19","author":"Eijken","year":"2005","journal-title":"Mol Endocrinol"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B187","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/1097-4644(20010601)81:3<453::AID-JCB1059>3.0.CO;2-Z","article-title":"Expression of 11\u03b2-hydroxysteroid dehydrogenase in rat osteoblastic cells: pre-receptor regulation of glucocorticoid responses in bone","volume":"81","author":"Eyre","year":"2001","journal-title":"J Cell Biochem"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B188","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1359\/jbmr.2002.17.6.979","article-title":"Osteoblastic 11\u03b2-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure","volume":"17","author":"Cooper","year":"2002","journal-title":"J Bone Miner Res"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B189","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1359\/jbmr.2001.16.6.1037","article-title":"Modulation of 11\u03b2-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation","volume":"16","author":"Cooper","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"7","key":"key\n\t\t\t\t20181005135519424_B190","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/art.34414","article-title":"Inflammatory regulation of glucocorticoid metabolism in mesenchymal stromal cells","volume":"64","author":"Ahasan","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"9","key":"key\n\t\t\t\t20181005135519424_B191","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1210\/me.2007-0489","article-title":"Glucocorticoid regulation of the promoter of 11\u03b2-hydroxysteroid dehydrogenase type 1 is indirect and requires CCAAT\/enhancer-binding protein-\u03b2","volume":"22","author":"Sai","year":"2008","journal-title":"Mol Endocrinol"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B192","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s12020-009-9245-4","article-title":"Stimulation of 11\u03b2-HSD1 expression by IL-1\u03b2 via a C\/EBP binding site in human fetal lung fibroblasts","volume":"36","author":"Yang","year":"2009","journal-title":"Endocrine"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B193","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/ard.2009.107466","article-title":"Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone loss","volume":"69","author":"Kaur","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B194","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.bone.2009.07.080","article-title":"HSD11B1 polymorphisms predicted bone mineral density and fracture risk in postmenopausal women without a clinically apparent hypercortisolemia","volume":"45","author":"Hwang","year":"2009","journal-title":"Bone"},{"issue":"1-2","key":"key\n\t\t\t\t20181005135519424_B195","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jsbmb.2010.11.009","article-title":"The 83,557insA variant of the gene coding 11\u03b2-hydroxysteroid dehydrogenase type 1 enzyme associates with serum osteocalcin in patients with endogenous Cushing\u2019s syndrome","volume":"123","author":"Szappanos","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"13","key":"key\n\t\t\t\t20181005135519424_B196","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.steroids.2012.08.014","article-title":"The rs4844880 polymorphism in the promoter region of the HSD11B1 gene associates with bone mineral density in healthy and postmenopausal osteoporotic women","volume":"77","author":"Feldman","year":"2012","journal-title":"Steroids"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B197","doi-asserted-by":"crossref","first-page":"E293","DOI":"10.1210\/jc.2013-1418","article-title":"Genetic polymorphisms in 11\u03b2-hydroxysteroid dehydrogenase type 1 correlate with the postdexamethasone cortisol levels and bone mineral density in patients evaluated for osteoporosis","volume":"99","author":"Siggelkow","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"26","key":"key\n\t\t\t\t20181005135519424_B198","doi-asserted-by":"crossref","first-page":"14924","DOI":"10.1073\/pnas.94.26.14924","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress","volume":"94","author":"Kotelevtsev","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"key\n\t\t\t\t20181005135519424_B199","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1210\/jc.2003-022025","article-title":"11\u03b2-Hydroxysteroid dehydrogenase type 1 activity predicts the effects of glucocorticoids on bone","volume":"88","author":"Cooper","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B200","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.coph.2013.03.003","article-title":"Targeting 11\u03b2-hydroxysteroid dehydrogenases: a novel approach to manipulating local glucocorticoid levels with implications for rheumatic disease","volume":"13","author":"Hardy","year":"2013","journal-title":"Curr Opin Pharmacol"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B201","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00223-011-9512-2","article-title":"Can 11\u03b2-hydroxysteroid dehydrogenase activity predict the sensitivity of bone to therapeutic glucocorticoids in inflammatory bowel disease","volume":"89","author":"Cooper","year":"2011","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B202","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/03009749609065648","article-title":"Bone loss in rheumatoid arthritis. Influence of disease activity, duration of the disease, functional capacity, and corticosteroid treatment","volume":"25","author":"Hansen","year":"1996","journal-title":"Scand J Rheumatol"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B203","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM199507203330302","article-title":"The effect of glucocorticoids on joint destruction in rheumatoid arthritis","volume":"333","author":"Kirwan","year":"1995","journal-title":"N Engl J Med"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B204","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/art.10083","article-title":"COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention","volume":"46","author":"Landew\u00e9","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"7","key":"key\n\t\t\t\t20181005135519424_B205","first-page":"1282","article-title":"Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis","volume":"25","author":"Gough","year":"1998","journal-title":"J Rheumatol"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B206","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/qjmed\/93.2.105","article-title":"Use of oral corticosteroids in the United Kingdom","volume":"93","author":"van Staa","year":"2000","journal-title":"QJM"},{"issue":"7053","key":"key\n\t\t\t\t20181005135519424_B207","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bmj.313.7053.344","article-title":"Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study","volume":"313","author":"Walsh","year":"1996","journal-title":"BMJ"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B208","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/acr.21796","article-title":"Prevalence of oral glucocorticoid usage in the United States: a general population perspective","volume":"65","author":"Overman","year":"2013","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B209","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s00198-014-2883-2","article-title":"International management of bone health in glucocorticoid-exposed individuals in the observational GLOW study","volume":"26","author":"Silverman","year":"2015","journal-title":"Osteoporos Int"},{"issue":"11","key":"key\n\t\t\t\t20181005135519424_B210","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/ker017","article-title":"Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years","volume":"50","author":"Fardet","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"key\n\t\t\t\t20181005135519424_B211","doi-asserted-by":"crossref","first-page":"e015237","DOI":"10.1136\/bmjopen-2016-015237","article-title":"Systemic glucocorticoid use in Denmark: a population-based prevalence study","volume":"7","author":"Laugesen","year":"2017","journal-title":"BMJ Open"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B212","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.2001.16.3.581","article-title":"Use of inhaled corticosteroids and risk of fractures","volume":"16","author":"Van Staa","year":"2001","journal-title":"J Bone Miner Res"},{"issue":"12","key":"key\n\t\t\t\t20181005135519424_B213","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","article-title":"Oral corticosteroids and fracture risk: relationship to daily and cumulative doses","volume":"39","author":"van Staa","year":"2000","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"key\n\t\t\t\t20181005135519424_B214","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1007\/s00198-016-3646-z","article-title":"Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis","volume":"27","author":"Balasubramanian","year":"2016","journal-title":"Osteoporos Int"},{"issue":"9","key":"key\n\t\t\t\t20181005135519424_B215","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s00198-013-2352-3","article-title":"Influence of recency and duration of glucocorticoid use on bone mineral density and risk of fractures: population-based cohort study","volume":"24","author":"Majumdar","year":"2013","journal-title":"Osteoporos Int"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B216","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/art.22294","article-title":"Fracture risk with intermittent high-dose oral glucocorticoid therapy","volume":"56","author":"De Vries","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20181005135519424_B217","doi-asserted-by":"crossref","first-page":"j1415","DOI":"10.1136\/bmj.j1415","article-title":"Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study","volume":"357","author":"Waljee","year":"2017","journal-title":"BMJ"},{"issue":"11","key":"key\n\t\t\t\t20181005135519424_B218","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K","article-title":"Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study","volume":"42","author":"Cohen","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B219","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJM199708073370603","article-title":"Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis","volume":"337","author":"Adachi","year":"1997","journal-title":"N Engl J Med"},{"issue":"5","key":"key\n\t\t\t\t20181005135519424_B220","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","article-title":"Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"339","author":"Saag","year":"1998","journal-title":"N Engl J Med"},{"issue":"5","key":"key\n\t\t\t\t20181005135519424_B221","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00198-015-3455-9","article-title":"Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials","volume":"27","author":"Amiche","year":"2016","journal-title":"Osteoporos Int"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B222","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00198-015-3077-2","article-title":"Cortical thinning and progressive cortical porosity in female patients with systemic lupus erythematosus on long-term glucocorticoids: a 2-year case-control study","volume":"26","author":"Zhu","year":"2015","journal-title":"Osteoporos Int"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B223","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00198-015-3078-1","article-title":"The impact of glucocorticoid therapy on trabecular bone score in older women","volume":"26","author":"Paggiosi","year":"2015","journal-title":"Osteoporos Int"},{"issue":"12","key":"key\n\t\t\t\t20181005135519424_B224","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1177\/1352458514566417","article-title":"Short-term, high-dose glucocorticoid treatment does not contribute to reduced bone mineral density in patients with multiple sclerosis","volume":"21","author":"Olsson","year":"2015","journal-title":"Mult Scler"},{"issue":"8","key":"key\n\t\t\t\t20181005135519424_B225","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1093\/qjmed\/hcv012","article-title":"Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures: a population-based cohort study","volume":"108","author":"Chen","year":"2015","journal-title":"QJM"},{"issue":"8","key":"key\n\t\t\t\t20181005135519424_B226","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.40137","article-title":"2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"69","author":"Buckley","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"key\n\t\t\t\t20181005135519424_B227","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00198-012-1958-1","article-title":"Joint IOF-ECTS GIO Guidelines Working Group. A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis","volume":"23","author":"Lekamwasam","year":"2012","journal-title":"Osteoporos Int"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B228","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11657-017-0324-5","article-title":"National Osteoporosis Guideline Group (NOGG). UK clinical guideline for the prevention and treatment of osteoporosis","volume":"12","author":"Compston","year":"2017","journal-title":"Arch Osteoporos"},{"issue":"9671","key":"key\n\t\t\t\t20181005135519424_B229","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(09)60250-6","article-title":"Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial","volume":"373","author":"Reid","year":"2009","journal-title":"Lancet"},{"issue":"20","key":"key\n\t\t\t\t20181005135519424_B230","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or alendronate in glucocorticoid-induced osteoporosis","volume":"357","author":"Saag","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B231","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W","article-title":"Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial","volume":"44","author":"Adachi","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"4","key":"key\n\t\t\t\t20181005135519424_B232","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s002230001146","article-title":"Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy","volume":"67","author":"Wallach","year":"2000","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B233","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s001980050118","article-title":"Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis","volume":"9","author":"Reginster","year":"1999","journal-title":"Osteoporos Int"},{"issue":"4","key":"key\n\t\t\t\t20181005135519424_B234","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s002239900708","article-title":"Treatment of glucocorticoid-induced osteoporosis with alfacalcidol\/calcium versus vitamin D\/calcium","volume":"65","author":"Ringe","year":"1999","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"key\n\t\t\t\t20181005135519424_B235","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJMoa053569","article-title":"Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis","volume":"355","author":"de Nijs","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B236","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/jbmr.1870","article-title":"Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial","volume":"28","author":"Gluer","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"9","key":"key\n\t\t\t\t20181005135519424_B237","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.39726","article-title":"Trabecular bone score in patients with chronic glucocorticoid therapy-induced osteoporosis treated with alendronate or teriparatide","volume":"68","author":"Saag","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"key\n\t\t\t\t20181005135519424_B238","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00198-014-3022-9","article-title":"Fracture rate associated with quality metric-based anti-osteoporosis treatment in glucocorticoid-induced osteoporosis","volume":"26","author":"Overman","year":"2015","journal-title":"Osteoporos Int"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B239","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2017.8040","article-title":"Association between alendronate use and hip fracture risk in older patients using oral prednisolone","volume":"318","author":"Axelsson","year":"2017","journal-title":"JAMA"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B240","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1210\/jc.2017-01912","article-title":"Alendronate use and the risk of nonvertebral fracture during glucocorticoid therapy: a retrospective cohort study","volume":"103","author":"Bergman","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key\n\t\t\t\t20181005135519424_B241","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/jbmr.2497","article-title":"Bone tissue properties measurement by reference point indentation in glucocorticoid-induced osteoporosis","volume":"30","author":"Mellibovsky","year":"2015","journal-title":"J Bone Miner Res"},{"issue":"19","key":"key\n\t\t\t\t20181005135519424_B242","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1056\/NEJMc0910389","article-title":"Atypical femoral fractures and bisphosphonate use","volume":"362","author":"Girgis","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B243","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3109\/17453674.2015.1004149","article-title":"Risk of atypical femoral fracture during and after bisphosphonate use","volume":"86","author":"Schilcher","year":"2015","journal-title":"Acta Orthop"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B244","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S2213-8587(18)30075-5","article-title":"Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study","volume":"6","author":"Saag","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B245","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11657-017-0336-1","article-title":"The clinical benefits of denosumab for prophylaxis of steroid-induced osteoporosis in patients with pulmonary disease","volume":"12","author":"Ishiguro","year":"2017","journal-title":"Arch Osteoporos"},{"issue":"6","key":"key\n\t\t\t\t20181005135519424_B246","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2169\/internalmedicine.56.7797","article-title":"Effects of denosumab on bone metabolic markers and bone mineral density in patients treated with glucocorticoids","volume":"56","author":"Sawamura","year":"2017","journal-title":"Intern Med"},{"key":"key\n\t\t\t\t20181005135519424_B247","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.bone.2015.03.002","article-title":"Switching of oral bisphosphonates to denosumab in chronic glucocorticoid users: a 12-month randomized controlled trial","volume":"75","author":"Mok","year":"2015","journal-title":"Bone"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B248","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2796.2011.02352.x","article-title":"Risk of hip fracture in Addison\u2019s disease: a population-based cohort study","volume":"270","author":"Bj\u00f6rnsdottir","year":"2011","journal-title":"J Intern Med"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B249","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/ard.46.1.81","article-title":"Myopathy in Addison\u2019s disease","volume":"46","author":"Mor","year":"1987","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B250","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/cen.12730","article-title":"What is the optimal bone-preserving strategy for patients with Addison\u2019s disease","volume":"83","author":"Lee","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"key\n\t\t\t\t20181005135519424_B251","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1210\/jc.2011-2036","article-title":"Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy","volume":"97","author":"Koetz","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B252","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s12020-017-1380-8","article-title":"Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison\u2019s disease on glucocorticoid and mineralocorticoid replacement therapy","volume":"59","author":"Camozzi","year":"2018","journal-title":"Endocrine"},{"issue":"4","key":"key\n\t\t\t\t20181005135519424_B253","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1530\/EJE-15-1096","article-title":"Reduction in daily hydrocortisone dose improves bone health in primary adrenal insufficiency","volume":"174","author":"Schulz","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"key\n\t\t\t\t20181005135519424_B254","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1530\/EJE-16-0104","article-title":"Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"175","author":"Ceccato","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"key\n\t\t\t\t20181005135519424_B255","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1515\/JPEM.2008.21.12.1155","article-title":"Bone mineral density in girls with classical congenital adrenal hyperplasia due to CYP21 deficiency","volume":"21","author":"Elnecave","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B256","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/cen.12507","article-title":"Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"82","author":"El-Maouche","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"12","key":"key\n\t\t\t\t20181005135519424_B257","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1210\/jc.2007-0744","article-title":"Fractures and bone mineral density in adult women with 21-hydroxylase deficiency","volume":"92","author":"Falhammar","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"key\n\t\t\t\t20181005135519424_B258","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/EJE-12-0865","article-title":"Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia","volume":"168","author":"Falhammar","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t20181005135519424_B259","doi-asserted-by":"crossref","first-page":"11505","DOI":"10.1038\/ncomms11505","article-title":"A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair","volume":"7","author":"Florio","year":"2016","journal-title":"Nat Commun"},{"issue":"4","key":"key\n\t\t\t\t20181005135519424_B260","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1124\/mol.107.038794","article-title":"Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor","volume":"72","author":"Newton","year":"2007","journal-title":"Mol Pharmacol"},{"issue":"11","key":"key\n\t\t\t\t20181005135519424_B261","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/jbmr.1753","article-title":"Selective glucocorticoid receptor agonists: glucocorticoid therapy with no regrets","volume":"27","author":"Cooper","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"11","key":"key\n\t\t\t\t20181005135519424_B262","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/jbmr.1688","article-title":"Selective glucocorticoid receptor modulation maintains bone mineral density in mice","volume":"27","author":"Thiele","year":"2012","journal-title":"J Bone Miner Res"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/39\/5\/519\/25900120\/er.2018-00097.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,19]],"date-time":"2019-10-19T07:45:06Z","timestamp":1571471106000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/39\/5\/519\/5036716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,13]]},"references-count":262,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,6,13]]},"published-print":{"date-parts":[[2018,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2018-00097","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,10]]},"published":{"date-parts":[[2018,6,13]]}}}